{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T16:40:37Z","timestamp":1793378437768,"version":"4.5.0"},"reference-count":44,"publisher":"American Medical Association (AMA)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Oncol"],"published-print":{"date-parts":[[2024,1,1]]},"abstract":"Importance<\/jats:title>New strategies targeting waste are required to improve financial and ecologic sustainability of expensive therapies, such as oral anticancer drugs, that frequently remain unused by patients. Redispensing unused oral anticancer drugs seems to be a promising strategy when drug quality is guaranteed.<\/jats:p><\/jats:sec>Objectives<\/jats:title>To determine the waste reduction and net cost savings attained by redispensing oral anticancer drugs that go unused by patients compared with the standard practice of disposal.<\/jats:p><\/jats:sec>Design, Settings, and Participants<\/jats:title>The ROAD study was a prospective single-group intervention conducted in the outpatient pharmacies of 4 hospitals in the Netherlands from February 1, 2021, to February 1, 2023, with 12-month follow-up of each patient. Patients with cancer and who had a prescription for an oral anticancer drug that could be stored at room temperature were included. Of 2426 eligible patients, 602 did not consent and 601 did not respond. Data analyses were performed from August 25, 2022, to April 19, 2023.<\/jats:p><\/jats:sec>Intervention<\/jats:title>Participants received oral anticancer drugs for use at home in special packaging (ie, sealed packaging with time-temperature indicator), to be returned to the pharmacy should these remain unused. The pharmacy ensured quality of returned drugs based on authenticity, appearance, remaining shelf life and adequate storage temperature. Drugs fulfilling quality requirements were redispensed to other patients.<\/jats:p><\/jats:sec>Main Outcome and Measure<\/jats:title>Total waste reduction and mean net annual cost savings per patient compared with the standard practice of disposal. Optimization of cost savings was explored by introducing variations in the quality assurance procedure and patient population. All analyses used the average exchange rate for 2021 \u20ac1\u2009=\u2009US $1.18.<\/jats:p><\/jats:sec>Results<\/jats:title>Of 1223 patients with cancer who consented, 1071 participated (median [IQR] age, 70 [62-75] years; 622 [58.1%] were male). In all, 171 patients (16.0%; 95% CI, 13.8%-18.3%) returned 335 unused oral anticancer drug packages. Of the returned drugs, 228 packages were redispensed, which reduced waste by 68.1% (95% CI, 67.7%-68.5%) compared with the standard practice (disposal). Redispensing unused oral anticancer drugs comprised 2.4% (95% CI, 2.2%-2.5%) of total drug costs, providing mean net annual cost savings of US $680 (95% CI, $524-$837) up to $1591 (95% CI, $1226-$2002) per participant.<\/jats:p><\/jats:sec>Conclusions and Relevance<\/jats:title>The findings of this multicenter intervention study indicate that redispensing unused oral anticancer drugs is associated with waste reduction and cost savings, which in turn may improve the affordability and sustainability of cancer treatment.<\/jats:p><\/jats:sec>Trial Registration<\/jats:title>World Health Organization International Clinical Trials Registry Platform Identifier: NL9208<\/jats:ext-link><\/jats:p><\/jats:sec>","DOI":"10.1001\/jamaoncol.2023.4865","type":"journal-article","created":{"date-parts":[[2023,11,16]],"date-time":"2023-11-16T16:01:07Z","timestamp":1700150467000},"page":"87","source":"Crossref","is-referenced-by-count":37,"title":["Cost Savings and Waste Reduction Through Redispensing Unused Oral Anticancer Drugs"],"prefix":"10.1001","volume":"10","author":[{"given":"Elisabeth M.","family":"Smale","sequence":"first","affiliation":[{"name":"Department of Pharmacy, Radboud University Medical Center, Nijmegen, the Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bart J. F.","family":"van den Bemt","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, Radboud University Medical Center, Nijmegen, the Netherlands"},{"name":"Department of Pharmacy, Sint Maartenskliniek, Ubbergen, the Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eibert R.","family":"Heerdink","sequence":"additional","affiliation":[{"name":"Department of Clinical Pharmacy, Division of Laboratory, Genetics and Pharmacy, University Medical Centre Utrecht, Utrecht, the Netherlands"},{"name":"Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Faculty of Science, Utrecht, the Netherlands"},{"name":"Research Group Innovations of Pharmaceutical Care, Utrecht University of Applied Medical Centre Utrecht, Utrecht, the Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ingrid M. E.","family":"Desar","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology, Radboud University Medical Center, Nijmegen, the Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toine C. G.","family":"Egberts","sequence":"additional","affiliation":[{"name":"Department of Clinical Pharmacy, Division of Laboratory, Genetics and Pharmacy, University Medical Centre Utrecht, Utrecht, the Netherlands"},{"name":"Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Faculty of Science, Utrecht, the Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charlotte L.","family":"Bekker","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, Radboud University Medical Center, Nijmegen, the Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"ROAD Study Group","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anneloes","family":"de Bruin","sequence":"additional","affiliation":[{"name":"for the ROAD Study Group"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bas","family":"van Vlijmen","sequence":"additional","affiliation":[{"name":"for the ROAD Study Group"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Desir\u00e9e","family":"Burger","sequence":"additional","affiliation":[{"name":"for the ROAD Study Group"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thijs","family":"Balk","sequence":"additional","affiliation":[{"name":"for the ROAD Study Group"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","reference":[{"issue":"7","key":"coi230063r2","doi-asserted-by":"publisher","first-page":"e271","DOI":"10.1016\/S2542-5196(20)30121-2","article-title":"The environmental footprint of health care: a global assessment.","volume":"4","author":"Lenzen","year":"2020","journal-title":"Lancet Planet Health"},{"issue":"10007","key":"coi230063r3","doi-asserted-by":"publisher","first-page":"1973","DOI":"10.1016\/S0140-6736(15)60901-1","article-title":"Safeguarding human health in the Anthropocene epoch: report of The Rockefeller Foundation-Lancet Commission on Planetary Health.","volume":"386","author":"Whitmee","year":"2015","journal-title":"Lancet"},{"key":"coi230063r4","doi-asserted-by":"publisher","DOI":"10.1016\/j.scp.2021.100400","article-title":"Waste-minimising measures to achieve sustainable supply and use of medication.","volume":"20","author":"Smale","year":"2021","journal-title":"Sustain Chem Pharm"},{"issue":"3","key":"coi230063r6","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1111\/ijpp.12391","article-title":"How do people conceptualise the reuse of medicines? an interview study.","volume":"26","author":"Alhamad","year":"2018","journal-title":"Int J Pharm Pract"},{"issue":"6","key":"coi230063r7","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1111\/ijpp.12275","article-title":"The redistribution of medicines: could it become a reality?","volume":"24","author":"McRae","year":"2016","journal-title":"Int J Pharm Pract"},{"issue":"1","key":"coi230063r8","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1007\/s11096-017-0424-8","article-title":"Redispensing of medicines unused by patients: a qualitative study among stakeholders.","volume":"39","author":"Bekker","year":"2017","journal-title":"Int J Clin Pharm"},{"issue":"8","key":"coi230063r10","doi-asserted-by":"publisher","first-page":"3329","DOI":"10.1016\/j.sapharm.2021.12.004","article-title":"Key factors underlying the willingness of patients with cancer to participate in medication redispensing.","volume":"18","author":"Smale","year":"2022","journal-title":"Res Social Adm Pharm"},{"issue":"2","key":"coi230063r11","doi-asserted-by":"publisher","first-page":"77","DOI":"10.3390\/pharmacy9020077","article-title":"Public attitudes towards medicinal waste and medicines reuse in a \u2018free prescription\u2019 healthcare system.","volume":"9","author":"McRae","year":"2021","journal-title":"Pharmacy (Basel)"},{"issue":"2","key":"coi230063r12","doi-asserted-by":"publisher","first-page":"58","DOI":"10.3390\/pharmacy8020058","article-title":"Enhancing pharmaceutical packaging through a technology ecosystem to facilitate the reuse of medicines and reduce medicinal waste.","volume":"8","author":"Hui","year":"2020","journal-title":"Pharmacy (Basel)"},{"issue":"3","key":"coi230063r13","doi-asserted-by":"publisher","first-page":"128","DOI":"10.3390\/pharmacy9030128","article-title":"The effect of quality indicators on beliefs about medicines reuse: an experimental study.","volume":"9","author":"Lam","year":"2021","journal-title":"Pharmacy (Basel)"},{"issue":"10","key":"coi230063r14","doi-asserted-by":"publisher","first-page":"1457","DOI":"10.18553\/jmcp.2021.27.10.1457","article-title":"Treatment utilization patterns of newly initiated oral anticancer agents in a national sample of Medicare beneficiaries.","volume":"27","author":"Doshi","year":"2021","journal-title":"J Manag Care Spec Pharm"},{"issue":"7","key":"coi230063r15","doi-asserted-by":"publisher","first-page":"669","DOI":"10.18553\/jmcp.2014.20.7.669","article-title":"Out-of-pocket costs and oral cancer medication discontinuation in the elderly.","volume":"20","author":"Kaisaeng","year":"2014","journal-title":"J Manag Care Spec Pharm"},{"issue":"1","key":"coi230063r16","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1177\/1078155214547664","article-title":"Utilization patterns for oral oncology medications in a specialty pharmacy cycle management program.","volume":"22","author":"Deutsch","year":"2016","journal-title":"J Oncol Pharm Pract"},{"issue":"18","key":"coi230063r17","doi-asserted-by":"publisher","first-page":"1983","DOI":"10.1200\/JCO.20.03088","article-title":"The randomized AMBORA Trial: impact of pharmacological\/pharmaceutical care on medication safety and patient-reported outcomes during treatment with new oral anticancer agents.","volume":"39","author":"D\u00fcrr","year":"2021","journal-title":"J Clin Oncol"},{"issue":"1","key":"coi230063r18","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1016\/j.sapharm.2018.03.064","article-title":"Quantity and economic value of unused oral anti-cancer and biological disease-modifying anti-rheumatic drugs among outpatient pharmacy patients who discontinue therapy.","volume":"15","author":"Bekker","year":"2019","journal-title":"Res Social Adm Pharm"},{"issue":"8","key":"coi230063r19","doi-asserted-by":"publisher","first-page":"e1247","DOI":"10.1200\/OP.21.00847","article-title":"Economic cost and sustainability of oral therapies in precision oncology.","volume":"18","author":"Desai","year":"2022","journal-title":"JCO Oncol Pract"},{"issue":"15","key":"coi230063r21","doi-asserted-by":"publisher","first-page":"1501","DOI":"10.1001\/jama.2019.13978","article-title":"Waste in the US health care system: estimated costs and potential for savings.","volume":"322","author":"Shrank","year":"2019","journal-title":"JAMA"},{"issue":"4","key":"coi230063r22","doi-asserted-by":"publisher","first-page":"824","DOI":"10.1177\/1078155218762596","article-title":"Financial impact of oral chemotherapy wastage on society and the patient.","volume":"25","author":"Monga","year":"2019","journal-title":"J Oncol Pharm Pract"},{"key":"coi230063r23","first-page":"46","article-title":"Guidelines for reporting non-randomised studies.","volume":"11","author":"Reeves","year":"2004","journal-title":"Forsch Komplementarmed Klass Naturheilkd"},{"key":"coi230063r24","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1016\/j.tmaid.2019.02.005","article-title":"Redispensing of unused HIV post-exposure prophylaxis for medical students.","volume":"29","author":"Bekker","year":"2019","journal-title":"Travel Med Infect Dis"},{"issue":"1","key":"coi230063r26","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1186\/s12913-019-4065-6","article-title":"What does it cost to redispense unused medications in the pharmacy? a micro-costing study.","volume":"19","author":"Bekker","year":"2019","journal-title":"BMC Health Serv Res"},{"issue":"3","key":"coi230063r28","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1634\/theoncologist.2018-0565","article-title":"Recycling discarded drugs: improving access to oral antineoplastic drugs.","volume":"24","author":"Layton","year":"2019","journal-title":"Oncologist"},{"issue":"5","key":"coi230063r29","article-title":"Prescription drug reuse and recycling.","volume":"34","author":"Crews","year":"2019","journal-title":"Oncol Issues"},{"issue":"1","key":"coi230063r30","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1177\/0269216316639798","article-title":"Turning waste medicines to cost savings: a pilot study on the feasibility of medication recycling as a solution to drug wastage.","volume":"31","author":"Toh","year":"2017","journal-title":"Palliat Med"},{"issue":"2","key":"coi230063r32","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1007\/BF01405730","article-title":"Dilemmas in a general theory of planning.","volume":"4","author":"Rittel","year":"1973","journal-title":"Policy Sci"},{"issue":"12","key":"coi230063r33","doi-asserted-by":"publisher","first-page":"5074","DOI":"10.1111\/bcp.15509","article-title":"The Dutch chain approach on pharmaceuticals in water: stakeholders acting together to reduce the environmental impact of pharmaceuticals.","volume":"88","author":"Moermond","year":"2022","journal-title":"Br J Clin Pharmacol"},{"issue":"5","key":"coi230063r35","doi-asserted-by":"publisher","first-page":"618","DOI":"10.6004\/jnccn.2012.0063","article-title":"Oral chemotherapy program improves adherence and reduces medication wastage and hospital admissions.","volume":"10","author":"Khandelwal","year":"2012","journal-title":"J Natl Compr Canc Netw"},{"issue":"10","key":"coi230063r36","doi-asserted-by":"publisher","first-page":"e856","DOI":"10.1200\/JOP.19.00069","article-title":"Estimated cost and savings in a patient management program for oral oncology medications impact of split fill component.","volume":"15","author":"Staskon","year":"2019","journal-title":"J Oncol Pract"},{"issue":"3","key":"coi230063r37","first-page":"75","article-title":"Evaluating the Effects of a 14-Day Oral Chemotherapy Dispensing Protocol on Adherence, Toxicity, and Cost.","volume":"5","author":"Young","year":"2015","journal-title":"J Hematol Oncol Pharm"},{"issue":"4","key":"coi230063r38","doi-asserted-by":"publisher","first-page":"e618","DOI":"10.1200\/OP.22.00553","article-title":"Feasibility of an individualized dispensing program for patients prescribed oral anticancer drugs to prevent waste.","volume":"19","author":"Smale","year":"2023","journal-title":"JCO Oncol Pract"},{"issue":"10","key":"coi230063r39","doi-asserted-by":"publisher","first-page":"1365","DOI":"10.1016\/j.sapharm.2023.06.004","article-title":"How to engage healthcare providers in preventing medication waste through individualized prescribing and dispensing: a qualitative study.","volume":"19","author":"Smale","year":"2023","journal-title":"Res Social Adm Pharm"},{"issue":"36","key":"coi230063r40","doi-asserted-by":"publisher","first-page":"e11","DOI":"10.1200\/EDBK_156142","article-title":"Strategies for sustainable cancer care.","volume":"35","author":"Kerr","year":"2016","journal-title":"Am Soc Clin Oncol Educ Book"},{"issue":"3","key":"coi230063r42","doi-asserted-by":"publisher","first-page":"e94","DOI":"10.1177\/1578.17246","article-title":"\u201cGreen Oncology\u201d: the Italian medical oncologists\u2019 challenge to reduce the ecological impact of their clinical activity.","volume":"100","author":"Bretti","year":"2014","journal-title":"Tumori"},{"issue":"4","key":"coi230063r43","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1016\/S1470-2045(22)00073-0","article-title":"Price changes and within-class competition of cancer drugs in the USA and Europe: a comparative analysis.","volume":"23","author":"Vokinger","year":"2022","journal-title":"Lancet Oncol"},{"key":"coi230063r5","volume-title":"Making Medicines Affordable: A National Imperative","author":"National Academies of Sciences, Engineering and Medicine, Health and Medicine Division, Board on Health Care Services, Committee on Ensuring Patient Access to Affordable Drug Therapies","year":"2017"},{"key":"coi230063r27","volume-title":"Costing guide: methods of cost research and reference pricing for economic evaluations in healthcare","author":"Hakkaart-van Roijen","year":"2015"},{"key":"coi230063r1","doi-asserted-by":"crossref","unstructured":"Organisation for Economic Co-operation and Development Health Policy Studies. Pharmaceutical Innovation and Access to Medicines. 2018. Accessed October 16, 2023. doi:10.1787\/9789264307391-en","DOI":"10.1787\/9789264307391-en"},{"key":"coi230063r9","doi-asserted-by":"crossref","unstructured":"Donyai? P, McCrindle? R, Hui? T, Sherratt? R. Stakeholder Views on the idea of medicines reuse in the UK. Pharm (Basel). 2021;9:85.","DOI":"10.3390\/pharmacy9020085"},{"key":"coi230063r20","unstructured":"Organisation for Economic Co-operation and Development Health Policy Studies Health Division. Directorate for Employment Labour and Social Affairs. Addressing Challenges in Access to Oncology Medicines. Analytical Report. 2020. Accessed October 16, 2023. https:\/\/www.oecd.org\/health\/health-systems\/Addressing-Challenges-in-Access-to-Oncology-Medicines-Analytical-Report.pdf"},{"key":"coi230063r25","unstructured":"National Health Care Institute. Medicine Costs [Dutch]. 2022. Accessed 15 February, 2022. https:\/\/www.medicijnkosten.nl\/toelichting"},{"key":"coi230063r31","unstructured":"Smale? EM. The ROAD to sustainable medication use: redispensing unused oral anticancer drugs. World Health Organization International Clinical Trials Registry Platform. Accessed 3 August, 2022. https:\/\/trialsearch.who.int\/Trial2.aspx?TrialID=NL9208"},{"key":"coi230063r34","unstructured":"The European Parliament and The Council Of The European Union. Waste Framework Directive 2008\/98\/EC. 2009. Accessed October 16, 2023. https:\/\/eur-lex.europa.eu\/legal-content\/EN\/TXT\/?uri=celex%3A32008L0098"},{"key":"coi230063r41","unstructured":"European Society for Medical Oncology. Sustainable cancer care. Accessed January 16, 2023. https:\/\/www.esmo.org\/about-esmo\/from-esmo-vision-2020-to-esmo-vision-2025\/sustainable-cancer-care"},{"key":"coi230063r44","unstructured":"Mulcahy? AW, Whaley? CM, Gizaw? M, Schwam? D, Edenfield? N, Becerra-Ornelas? AU. International Prescription Drug Price Comparisons: Current Empirical Estimates and Comparisons with Previous Studies. 2021. https:\/\/aspe.hhs.gov\/reports\/international-prescription-drug-price-comparisons"}],"container-title":["JAMA Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamaoncology\/articlepdf\/2811990\/jamaoncology_smale_2023_oi_230063_1733967231.58509.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,19]],"date-time":"2024-12-19T16:03:24Z","timestamp":1734624204000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamaoncology\/fullarticle\/2811990"}},"subtitle":["The ROAD Study"],"short-title":[],"issued":{"date-parts":[[2024,1,1]]},"references-count":44,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2024,1,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamaoncol.2023.4865","relation":{},"ISSN":["2374-2437"],"issn-type":[{"value":"2374-2437","type":"print"}],"subject":[],"published":{"date-parts":[[2024,1,1]]}}}